Cleared Special

K131496 - BELLAVAR / CUSTOM SEAMLESS SOFT (A.K.A....

K131496 is the FDA 510(k) clearance for BELLAVAR / CUSTOM SEAMLESS SOFT (A.K.A.... by Bsn Medical, Inc.. It is a Class 2 General Hospital device (product code DWL) cleared through the Special 510(k) pathway after a 48-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
48d
Days
Class 2
Risk

K131496 is an FDA 510(k) clearance for the BELLAVAR / CUSTOM SEAMLESS SOFT (A.K.A. COMTESSE). Classified as Stocking, Medical Support (to Prevent Pooling Of Blood In Legs) (product code DWL), Class II - Special Controls.

Submitted by Bsn Medical, Inc. (Rutherford College, US). The FDA issued a Cleared decision on July 10, 2013 after a review of 48 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5780 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Bsn Medical, Inc. devices

Submission Details

510(k) Number K131496 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2013
Decision Date July 10, 2013
Days to Decision 48 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
81d faster than avg
Panel avg: 129d · This submission: 48d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code DWL Stocking, Medical Support (to Prevent Pooling Of Blood In Legs)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5780
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - DWL Stocking, Medical Support (to Prevent Pooling Of Blood In Legs)

All 9
Devices cleared under the same product code (DWL) and FDA review panel - the closest regulatory comparables to K131496.
MEDLINE ANTI-EMBOLISM STOCKING
K141127 · Medline Industries, Inc. · Aug 2014
FUTURO (TM) TRAVEL KNEE-HIGHS
K123085 · 3M Company · Dec 2012
CURAD COMPRESSION HOSIERY
K112769 · Medline Industries, Inc. · Mar 2012
ANTI-EMBOLISM STOCKINGS, MODELS 71055-00000-02, 71057-00000-02, 71059-00000-02, 71064-00000-02 & 71065-00000-02
K090921 · Beiersdorf, Inc. · Dec 2009
BOEHRINGER LABORATORIES PNEUMATIC AMBULATORY COMPRESSION SYSTEM 8200 SERIES
K020538 · Boehringer Laboratories · May 2002
KENDALL HOME RX THERAPEUTIC STOCKING
K925417 · Kendall Healthcare Products Co. Div.Of Tyco Health · Jun 1993